COMTAN

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, Tunisia, United States, South Africa

Active ingredients

The drug COMTAN contains one active pharmaceutical ingredient (API):

1 Entacapone UNII 4975G9NM6T - ENTACAPONE

Entacapone belongs to a new therapeutic class, catechol-O-methyl transferase (COMT) inhibitors. It is a reversible, specific, and mainly peripherally acting COMT inhibitor designed for concomitant administration with levodopa preparations. Entacapone prolongs the clinical response to levodopa. Read about Entacapone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COMTAN Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N04BX02	Entacapone	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents
Discover more medicines within N04BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8367J
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 511521030072811
Country: CA	Health Products and Food Branch	Identifier(s): 02243763
Country: EE	Ravimiamet	Identifier(s): 1200283, 1200294, 1200306
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 98081003
Country: FR	Base de données publique des médicaments	Identifier(s): 68826958
Country: HK	Department of Health Drug Office	Identifier(s): 44960
Country: JP	医薬品医療機器総合機構	Identifier(s): 1169014F1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028299, 1028300, 1028301, 1089148, 1089149, 1089150
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 52035
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8077
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100087162
Country: SG	Health Sciences Authority	Identifier(s): 11234P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283271
Country: US	FDA, National Drug Code	Identifier(s): 0078-0327, 52427-800
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/5.4.1/0684